Login Register Cart 0
Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5257
ISSN (Online): 1875-6182

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Outcome and Complications of Hemoperfusion in Patients with COVID-19 in Intensive Care Unit: A Cross-Sectional Study

Author(s): Mahboobeh Darban, Maliheh Yarmohamadi, Majid Mir Mohammadkhani and Saeedehsadat Mousavizade Jazaeri*

Volume 21, Issue 1, 2023

Published on: 10 August, 2022

Page: [60 - 66] Pages: 7

DOI: 10.2174/1871525720666220514164855

Price: $65

Abstract

Background & Objective: The use of the hemoperfusion method is recommended for treating cytokine storms and reducing complications in patients with COVID-19. The side effects of this treatment are not known; therefore, this study was performed to determine the final outcome and complications of hemoperfusion in patients with COVID-19 hospitalized in ICU.

Methods: In this retrospective cross-sectional study, all patients with severe COVID-19 without any comorbidities or organ failure underwent hemoperfusion treatment in ICU at Kosar Hospital in Semnan, Iran, from March to November 2021 were included. The clinical data and short-term complications up to 10 days after hemoperfusion and the final outcome were extracted from medical files.

Results: The mean age of 40 patients with severe COVID-19 undergoing hemoperfusion was 57.5±15.9 years. Most (24, 60%) patients were male. The time interval from hospitalization to hemoperfusion and the time interval between hemoperfusion and final outcome was 4.85 days and 8.30 days, respectively. Arrhythmia, bleeding, thrombocytopenia, and coagulation disorders were the most common short-term complications of hemoperfusion in patients with COVID-19, respectively. Most complications occurred on the second and third days after hemoperfusion. Mortality occurred in 20 (50 %) patients with severe COVID-19 undergoing hemoperfusion in ICU.

Conclusion: It seems that the short-term complications and deaths due to hemoperfusion are relatively high in patients with COVID-19 admitted to the ICU. Further studies are recommended.

Keywords: COVID-19, SARS-CoV-2, hemoperfusion, intensive care unit, mortality, coagulation disorders.

« Previous Next »
Graphical Abstract

[1]
Cucinotta, D.; Vanelli, M. WHO Declares COVID-19 a Pandemic. Acta Biomed., 2020, 91(1), 157-160.
[http://dx.doi.org/10.23750/abm.v91i1.9397 ] [PMID: 32191675]
[2]
Zamani, M.; Poustchi, H.; Mohammadi, Z.; Dalvand, S.; Sharafkhah, M.; Motevalian, S.A.; Eslami, S.; Emami, A.; Somi, M.H.; Yazdani-Charati, J.; Saki, N.; Karami, M.; Najafi, F.; Mohebbi, I.; Veisi, N.; Hormati, A.; Pourfarzi, F.; Ghadimi, R.; Ansari-Moghaddam, A.; Sharifi, H.; Roshandel, G.; Mansour-Ghanaei, F.; Joukar, F.; Shayanrad, A.; Eghtesad, S.; Niavarani, A.; Delavari, A.; Kaveh, S.; Feizesani, A.; Markarian, M.; Shafighian, F.; Sadjadi, A.; Darvishian, M.; Malekzadeh, R. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large populationbased cross-sectional study. BMC Public Health, 2022, 22(1), 1031.
[http://dx.doi.org/10.1186/s12889-022-13464-7]
[3]
Swann, J.; Hosseiniara, M. Possible causes of COVID-19 waves in Iran. Novelty Clini Med., 2022, 1(1), 1-3.
[http://dx.doi.org/10.22034/ncm.2022.140282]
[4]
Wu, Z.; McGoogan, J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 2020, 323(13), 1239-1242.
[http://dx.doi.org/10.1001/jama.2020.2648] [PMID: 32091533]
[5]
Ruan, Q.; Yang, K.; Wang, W.; Jiang, L.; Song, J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med., 2020, 46(5), 846-848.
[http://dx.doi.org/10.1007/s00134-020-05991-x] [PMID: 32125452]
[6]
Hu, B.; Huang, S.; Yin, L. The cytokine storm and COVID-19. J. Med. Virol., 2021, 93(1), 250-256.
[http://dx.doi.org/10.1002/jmv.26232] [PMID: 32592501]
[7]
Mehdi, M.; Javad, H.; Seyed-Mostafa, H.Z.; Mohammadreza, M.; Ebrahim, M. The effect of Persian shallot (Allium hirtifolium Boiss.) extract on blood sugar and serum levels of some hormones in diabetic rats. Pak. J. Pharm. Sci., 2013, 26(2), 397-402.
[PMID: 23455213]
[8]
Shimizu, T.; Hanasawa, K.; Sato, K.; Umeki, M.; Koga, N.; Naganuma, T.; Sato, S.; Shimonishi, T.; Ikeda, T.; Matsuno, N.; Ono, S.; Saitoh, H.; Satoh, K.; Otani, Y.; Endo, Y.; Eguchi, Y.; Tani, T. PMX Treatment Study Group. Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation. Langenbecks Arch. Surg., 2009, 394(2), 303-311.
[http://dx.doi.org/10.1007/s00423-008-0395-2] [PMID: 18685861]
[9]
Yatera, K.; Yamasaki, K.; Kawanami, T.; Tokuyama, S.; Ogoshi, T.; Kouzaki, M.; Nagata, S.; Nishida, C.; Yoshii, C.; Mukae, H. A case of successful treatment with polymyxin B-immobilized fiber column direct hemoperfusion in acute respiratory distress syndrome after influenza A infection. Intern. Med., 2011, 50(6), 601-605.
[http://dx.doi.org/10.2169/internalmedicine.50.4604] [PMID: 21422686]
[10]
Esmaeili Vardanjani, A.; Ronco, C.; Rafiei, H.; Golitaleb, M.; Pishvaei, M.H.; Mohammadi, M. Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19. Blood Purif., 2021, 50(2), 257-260.
[PMID: 32594085]
[11]
Kusaba, Y.; Izumi, S.; Takasaki, J.; Suzuki, M.; Katagiri, D.; Katsuno, T. Successful recovery from COVID-19-associated acute respiratory failure with polymyxin B-immobilized fiber column-direct hemoperfusion. Intern. Med., 2021, 5413-5420.
[PMID: 32863364]
[12]
Ahlström, B.; Frithiof, R.; Hultström, M.; Larsson, I.M.; Strandberg, G.; Lipcsey, M. The swedish COVID-19 intensive care cohort: Risk factors of ICU admission and ICU mortality. Acta Anaesthesiol. Scand., 2021, 65(4), 525-533.
[http://dx.doi.org/10.1111/aas.13781] [PMID: 33438198]
[13]
Gil, H.W.; Kim, S.J.; Yang, J.O.; Lee, E.Y.; Hong, S.Y. Clinical outcome of hemoperfusion in poisoned patients. Blood Purif., 2010, 30(2), 84-88.
[http://dx.doi.org/10.1159/000318585] [PMID: 20628243]
[14]
Quah, P.; Li, A.; Phua, J. Mortality rates of patients with COVID-19 in the intensive care unit: A systematic review of the emerging literature. Crit. Care, 2020, 24(1), 285.
[http://dx.doi.org/10.1186/s13054-020-03006-1] [PMID: 32498689]
[15]
Armstrong, R.A.; Kane, A.D.; Cook, T.M. Decreasing mortality rates in ICU during the COVID-19 pandemic. Anaesthesia, 2021, 76(Suppl. 3), 10.
[http://dx.doi.org/10.1111/anae.15230] [PMID: 32776536]
[16]
Katagiri, D.; Ishikane, M.; Asai, Y.; Izumi, S.; Takasaki, J.; Katsuoka, H.; Kondo, I.; Ide, S.; Nakamura, K.; Nakamoto, T.; Nomoto, H.; Akiyama, Y.; Miyazato, Y.; Suzuki, T.; Kinoshita, N.; Ogawa, T.; Togano, T.; Suzuki, M.; Hashimoto, M.; Sakamoto, K.; Kusaba, Y.; Katsuno, T.; Fukaya, T.; Hojo, M.; Sugiyama, M.; Mizokami, M.; Okamoto, T.; Kimura, A.; Noiri, E.; Ohmagari, N.; Hinoshita, F.; Sugiyama, H. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J. Clin. Apher., 2021, 36(3), 313-321.
[http://dx.doi.org/10.1002/jca.21861] [PMID: 33325084]
[17]
Mahesh, C.; Nagalakshmi, N.; Sivaparvathi, K.; Nagaraj, R.D.; Praveen, N.; Amarendra, N.R. Hemoperfusion in the management of acute poisoning. J. Dr. NTR Univ. Health Sci., 2020, 9(4), 250.
[http://dx.doi.org/10.4103/JDRNTRUHS.JDRNTRUHS_94_19]
[18]
Kochav, S.M.; Coromilas, E.; Nalbandian, A.; Ranard, L.S.; Gupta, A.; Chung, M.K.; Gopinathannair, R.; Biviano, A.B.; Garan, H.; Wan, E.Y. Cardiac arrhythmias in COVID-19 infection. Circ. Arrhythm. Electrophysiol., 2020, 13(6), e008719.
[http://dx.doi.org/10.1161/CIRCEP.120.008719] [PMID: 32434385]
[19]
Choi, S.W.; Shin, J.S.; Park, S.J.; Jung, E.; Park, Y.G.; Lee, J.; Kim, S.J.; Park, H.J.; Lee, J.H.; Park, S.M.; Moon, S.H.; Ban, K.; Go, Y.Y. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes. Antiviral Res., 2020, 184, 104955.
[http://dx.doi.org/10.1016/j.antiviral.2020.104955] [PMID: 33091434]
[20]
McLuckie, A.E.; Savage, R.W. Atrial fibrillation following pulse methylprednisolone therapy in an adult. Chest, 1993, 104(2), 622-623.
[http://dx.doi.org/10.1378/chest.104.2.622] [PMID: 8339660]
[21]
Shadvar, K.; Tagizadiyeh, A.; Gamari, A.A.; Soleimanpour, H.; Mahmoodpoor, A. Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm. Blood Purif., 2021, 50(3), 405-407.
[http://dx.doi.org/10.1159/000511391] [PMID: 33171470]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy